An Open-label, Non-comparative Study to Document the Tolerability to Ramipril in Patients With at Least One High Risk for Developing a Major Cardiovascular Event

NCT03099213 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
179
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi